Glycine

CHEMBL773 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
75.1 g/mol
LogP
-3.2
Phase
4

The simplest amino acid, used as a nutritional supplement and investigated for potential roles in treating neurological conditions such as Alzheimer's disease and bipolar disorder by modulating NMDA receptor activity in the brain. It serves as an inhibitory neurotransmitter in the spinal cord and brainstem and participates in the synthesis of proteins, creatine, and porphyrins. Research continues to explore its therapeutic potential across multiple conditions.

分子量

75.0700 g/mol

LogP

-3.20

TPSA

63.30 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCC(=O)O

InChI

InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)

Molecular Formula

C2H5NO2

HBD / HBA

2 / 3

回転可能結合数

1

重原子数

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The simplest amino acid, used as a nutritional supplement and investigated for potential roles in treating neurological conditions such as Alzheimer's disease and bipolar disorder by modulating NMDA receptor activity in the brain. It serves as an inhibitory neurotransmitter in the spinal cord and brainstem and participates in the synthesis of proteins, creatine, and porphyrins. Research continues to explore its therapeutic potential across multiple conditions.

Yes, Glycine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL773. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 750. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.